NC H12

Requires retailers to electronically submit pseudoephedrine sales information to the National Precursor Log Exchange (NPLEx) before completing sales, with system generating stop alerts if quantity limits would be exceeded.

Provides civil immunity to retailers using the electronic tracking system in good faith, except in cases of negligence, wantonness, recklessness, or deliberate misconduct.

Increases penalties for violations, making willful violations by retailers a Class A1 misdemeanor for first offense and Class I felony for second or subsequent offenses; prohibits sale of pseudoephedrine at establishments with three violations.

Requires State Bureau of Investigation to track methamphetamine laboratories discovered annually and report findings to the Legislative Commission on Methamphetamine Abuse by March 1 each year.

Directs Legislative Commission on Methamphetamine Abuse to study implementation effectiveness and potential costs of designating pseudoephedrine as Schedule III controlled substance, with final report due to the 2013 General Assembly.